GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » UBI Pharma Inc (ROCO:6562) » Definitions » Equity Investments

UBI Pharma (ROCO:6562) Equity Investments


View and export this data going back to 2016. Start your Free Trial

What is UBI Pharma Equity Investments?

Equity Investments only applies to insurance companies.


UBI Pharma (ROCO:6562) Business Description

Traded in Other Exchanges
N/A
Address
Number 45, Guangfu N. Road, Hukou Township, Hsinchu, TWN, 303
UBI Pharma Inc is a Taiwan-based pharmaceutical company. It is engaged in developing, manufacturing, and marketing of novel protein drugs and specialty injectables. Its products include Olanzapine, Levetiracetam, Lamivudine, Nevirapine, Efavirenz, and Terbutaline.